Home LiteratureArticle Details
PMID: 11895892 Published · ppublish English Comment Journal Article

Histone deacetylase inhibitors: a new class of potential therapeutic agents for cancer treatment.

Clinical cancer research : an official journal of the American Association for Cancer Research ·Vol. 8 ·No. 3 ·2002-03-00 ·Pages 662-4

Richon VM, O'Brien JP

Abstract

暂无摘要

MeSH Terms
Anti-Bacterial Agents/therapeutic use Antibiotics, Antineoplastic/therapeutic use Clinical Trials as Topic Depsipeptides Enzyme Inhibitors/therapeutic use Histone Deacetylase Inhibitors Histone Deacetylases/chemistry Humans Neoplasms/drug therapy Peptides, Cyclic
Chemicals
Anti-Bacterial Agents Antibiotics, Antineoplastic Depsipeptides Enzyme Inhibitors Histone Deacetylase Inhibitors Peptides, Cyclic romidepsin Histone Deacetylases
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Richon Victoria M
Aton Pharma, Inc., Tarrytown, New York 10591, USA. vrichon@atonpharma.com
O'Brien James P
Article Info
Journal
Clinical cancer research : an official journal of the American Association for Cancer Research
Abbr.
Clin Cancer Res
ISSN
1078-0432
Email
vrichon@atonpharma.com
Published
2002-03-00
Pages
662-4
Language
English
Region
United States
NLM ID
9502500
Subset
IM
Corrections
CommentOn
PMID: 11895901
External Links
PubMed source View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2